Trade

HealthCare Global Enterprises Ltd share price

Balanced risk
  • 29%Low risk
  • 29%Moderate risk
  • 29%Balanced risk
  • 29%High risk
  • 29%Extreme risk
  • 608.50(-1.07%)
    May 8, 2026 15:29:51 PM IST
    • NSE
    • BSE
  • Vol : 125.61 K (NSE + BSE)
    Last 20 day avg : 201.00 K

HealthCare Global Enterprises Ltd is trading -1.07% lower at Rs 608.50 as compared to its last closing price. HealthCare Global Enterprises Ltd has been trading in the price range of 625.40 & 602.00. There are 6 analysts who have initiated coverage on HealthCare Global Enterprises Ltd. There are 3 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -9.43 Crores in its last quarter.Listed peers of HealthCare Global Enterprises Ltd include Global Health (-1.45%), Fortis Healthcare (0.45%), Narayana Hrudayalaya (-2.06%).The Mutual Fund holding in HealthCare Global Enterprises Ltd was at 15.31% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in HealthCare Global Enterprises Ltd was at 2.76% in 31 Mar 2026. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 09, 2026, 02:29 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.16
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    1.99
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    8.73
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
602.00
Highest
625.40
52 week range
Lowest
511.83
Highest
799.36
HealthCare Global Enterprises Ltd Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Global Health
Moderately Bullish
1,196.80-1.4532,376.1461.739.450.0418.41
Fortis Healthcare
Bullish
951.800.4571,841.7580.047.640.1125.92
Narayana Hrudayalaya
Bullish
1,823.75-2.0637,388.7747.6610.510.2459.03
Max Healthcare Institute
Neutral
1,012.45-0.2698,511.4693.4311.210.1429.50
Apollo Hospitals Enterprise
Bullish
8,094.853.281,16,650.4971.0912.560.2683.18
Mutual Fund Ownership
View all
Motilal Oswal Business Cycle Fund Regular Growth
NA
  • Amount Invested (Cr.) 94.92
  • % of AUM 4.97
Motilal Oswal Multi Cap Fund Regular Growth
NA
  • Amount Invested (Cr.) 143.74
  • % of AUM 3.74
Samco Special Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 5.27
  • % of AUM 3.26
Tata India Pharma & Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 36.14
  • % of AUM 2.93
Tata Focused Equity Fund Regular Growth
3/5
  • Amount Invested (Cr.) 41.16
  • % of AUM 2.29
HealthCare Global Enterprises Ltd Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-19Audited Results
2026-02-17Rights issue of Equity Shares
2026-02-05Quarterly Results
2025-11-12Quarterly Results
2025-08-01Quarterly Results
About the company HealthCare Global Enterprises Ltd
  • IndustryHealthcare Facilities
  • ISININE075I01017
  • BSE Code539787
  • NSE Code
HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company offers cancer care, fertility treatment, advanced screening and diagnostic services, and tertiary care. It operates a cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company provides fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. The Triesta brand offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company operates a comprehensive cancer care center in Indore, Madhya Pradesh. It is also engaged in the radiation business in Indore, Madhya Pradesh. Its multispecialty hospitals deliver tertiary care for cardiac, bone and joint, brain, and spine.
  • Management Info
  • Manish MattooChief Executive Officer, Interim Chief Financial Officer, Executive Director
  • Manu DasChief Marketing Officer
  • Sunu Manuel AbeyCompliance Officer, Company Secretary
HealthCare Global Enterprises Ltd Share Price FAQs

HealthCare Global Enterprises Ltd is trading at 608.50 as on Fri May 08 2026 09:59:51. This is -1.07% lower as compared to its previous closing price of 615.10.

The market capitalization of HealthCare Global Enterprises Ltd is 9171.52 Cr as on Fri May 08 2026 09:59:51.

The average broker rating on HealthCare Global Enterprises Ltd is Strong Buy. The breakup of analyst rating is given below -

  • 3 analysts have given a strong buy rating
  • 3 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for HealthCare Global Enterprises Ltd is 799.36 whereas the 52 wk low is 511.83

HealthCare Global Enterprises Ltd can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: -
  • Dividend Yield: %
  • D/E ratio: -

HealthCare Global Enterprises Ltd reported a net profit of 44.41 Cr in 2025.

The Mutual Fund Shareholding was 15.31% at the end of 31 Mar 2026.